One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65,P < .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111,P < .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days,P < .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Eccles R. Common Cold Centre, Cardiff, UK. Available at: http://www.cf.ac.uk/biosi/ associates/cold/home.html.
Koch HP, Lawson LD.Garlic—The Science and Therapeutic Application of Allium Sativum L and Related Species. Baltimore: Williams & Wilkins; 1996.
Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic.Microbes Infect. 1999;2: 125–129.
Hanley AB, Fenwick CR. Cultivated alliums.J Plant Foods. 1985;6:211–238.
Data on file. Garlic Centre, East Sussex, UK.
About this article
Cite this article
Josling, P. Preventing the common cold with a garlic supplement: A double-blind, placebo-controlled survey. Adv Therapy 18, 189–193 (2001). https://doi.org/10.1007/BF02850113
- common cold
- garlic supplement